| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
|
Asahina, Hajime
|
|
|
22 |
2 |
p. 147-151
|
article
|
| 2 |
A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol
|
Shah, Rajiv
|
|
|
22 |
2 |
p. 142-146
|
article
|
| 3 |
CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma
|
Uprety, Dipesh
|
|
|
22 |
2 |
p. 71-73
|
article
|
| 4 |
Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non–small-cell Lung Cancer Brain Metastases
|
Enright, Tom L.
|
|
|
22 |
2 |
p. 110-119
|
article
|
| 5 |
Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non–small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report
|
Riudavets, Mariona
|
|
|
22 |
2 |
p. e215-e219
|
article
|
| 6 |
Concurrent Apatinib and Brain Radiotherapy in Patients With Brain Metastases From Driver Mutation-negative Non–small-cell Lung Cancer: Study Protocol for an Open-label Randomized Controlled Trial
|
Ma, Jia
|
|
|
22 |
2 |
p. e211-e214
|
article
|
| 7 |
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating Mood
|
van de Wiel, Mick
|
|
|
22 |
2 |
p. e146-e152
|
article
|
| 8 |
Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC
|
Takeyasu, Yuki
|
|
|
22 |
2 |
p. 127-133.e3
|
article
|
| 9 |
Editorial Board
|
|
|
|
22 |
2 |
p. A1
|
article
|
| 10 |
Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation
|
Lin, Gengpeng
|
|
|
22 |
2 |
p. e157-e159
|
article
|
| 11 |
Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non–small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results
|
Balasubramanian, Adithya
|
|
|
22 |
2 |
p. 74-82
|
article
|
| 12 |
Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling
|
Raz, Dan J.
|
|
|
22 |
2 |
p. 83-91
|
article
|
| 13 |
Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non–Small Cell Lung Cancers: Analysis of Five Cases
|
Suda, Kenichi
|
|
|
22 |
2 |
p. e141-e145
|
article
|
| 14 |
Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non–small-cell Lung Cancer: A Propensity Score Matching Study
|
Zhao, Yue
|
|
|
22 |
2 |
p. e201-e210
|
article
|
| 15 |
Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer
|
Citarella, Fabrizio
|
|
|
22 |
2 |
p. e137-e138
|
article
|
| 16 |
Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing
|
Sakane, Tadashi
|
|
|
22 |
2 |
p. 92-99.e4
|
article
|
| 17 |
Opportunistic Invasive Fungal Infections Mimicking Progression of Non–Small-Cell Lung Cancer
|
Park, Marian
|
|
|
22 |
2 |
p. e193-e200
|
article
|
| 18 |
Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer
|
Friis, Rasmus Blechingberg
|
|
|
22 |
2 |
p. e169-e179
|
article
|
| 19 |
Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer
|
Yamamoto, Nobuyuki
|
|
|
22 |
2 |
p. 134-141
|
article
|
| 20 |
Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non–Small-Cell Lung Cancer
|
Kamigaichi, Atsushi
|
|
|
22 |
2 |
p. 120-126.e3
|
article
|
| 21 |
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non–Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901)
|
Li, Xiang-Meng
|
|
|
22 |
2 |
p. 100-109.e3
|
article
|
| 22 |
Skip N2 Metastasis Shows Similar Prognosis to N1 Disease in Lung Cancer: Mechanism Discussion
|
Zhang, Jiaqi
|
|
|
22 |
2 |
p. e139-e140
|
article
|
| 23 |
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
|
Mountzios, Giannis
|
|
|
22 |
2 |
p. e180-e192
|
article
|
| 24 |
Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller
|
Zhang, Chong
|
|
|
22 |
2 |
p. e160-e168
|
article
|
| 25 |
Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection
|
Handa, Yoshinori
|
|
|
22 |
2 |
p. e224-e233
|
article
|
| 26 |
Table of Contents
|
|
|
|
22 |
2 |
p. A2-A6
|
article
|
| 27 |
Therapeutic Exposure and Successful Response to Pembrolizumab in a Patient With Non–Small-Cell Lung Cancer Despite Significant Renal Loss Due to Paraneoplastic Nephrotic Syndrome
|
Jansen, A.M.E.
|
|
|
22 |
2 |
p. e220-e223
|
article
|
| 28 |
Two Cases of Pulmonary Tumor Thrombotic Microangiopathy Associated with ROS1-Rearranged Non–Small-Cell Lung Cancer
|
Shah, Arpeet T.
|
|
|
22 |
2 |
p. e153-e156
|
article
|
Journal description